Citizen Health Secures $14.5M in Seed Funding to Revolutionize Rare Disease Care with AI-Powered Data Platform

Funding:
Citizen Health, a Silicon Valley-based startup, has raised $14.5 million in seed funding led by Transformation Capital, with participation from Wavemaker 360 and prominent angel investors1 2 3.

Partnership:
The funding is bolstered by a strategic program investment and partnership with the Chan Zuckerberg Initiative (CZI), focusing on accelerating rare disease drug development2 3.

Platform:
Citizen Health's AI-powered platform creates a comprehensive knowledge base that captures each patient's complete health journey, including clinical data, genetic information, imaging, and patient-reported outcomes2 3.

Patient Empowerment:
The platform empowers patients to manage their health data, share experiences with others, and direct how their data is used for research purposes, with explicit consent required for any data sharing1 2.

Revenue Model:
Citizen Health generates revenue by licensing patient data to pharmaceutical companies, with a portion of the revenue shared back with the patients and their associated advocacy groups2.

Rare Disease Focus:
The company aims to address the challenges faced by patients with rare diseases, which often lack approved therapies, by providing a platform for shared experiences and accelerating drug development3 4.

Future Plans:
Citizen Health plans to announce additional key partnerships and new product features in the coming months to further benefit patients and advance their mission3 5.